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Enterococci isolated from packaging areas of meat-processing facilities that
produce ready-to-eat meat products were examined for high-level vancomy-
cin resistance. A total of 406 enterococci isolates from the plants’ packaging
areas were examined for vancomycin resistance. High-level vancomycin
resistance was not demonstrated in any enterococci isolated from 12 meat-
processing plants. 
Since 1989, vancomycin-resistant enterococci (VRE)
have emerged as important nosocomial pathogens. In the
United States, the prevalence of VRE in hospitals has
increased from 0.3% in 1989 to 11%-13% by 1996 in patients
other than those in intensive care units (1). Currently in the
United States, more than half of all clinical isolates of
Enterococcus faecium are not treatable with vancomycin (2).
Another concern is that, as enterococci are found in the gas-
trointestinal tract of humans and animals, they may serve
as a reservoir of glycopeptide resistance genes that may be
transferred to other organisms such as methicillin-resistant
Staphylococcus aureus and S. epidermidis. 
The source of VRE is not known, although two potential
reservoirs for these organisms are hospitals and food ani-
mals fed growth promoters, such as avoparcin (3,4). Padigli-
one et al. (5) found that human fecal colonization with VRE
is uncommon in Australia, despite the relatively high level of
consumption of avoparcin by industry (10,000 kg/year). In
Europe, there have been numerous reports of VRE isolated
from food animals and food products (4,6,7). In the United
States, Knudtson and Hartman (8) studied the prevalence of
antimicrobial resistance in enterococci from water, pork, and
clinical isolates. In their studies, no VRE was detected from
pork carcasses or fresh or spoiled pork products. Also in the
United States, Coque et al. (9) and Thal et al. (10) studied
enterococci from animal sources and did not recover VRE
from the samples examined.
Avoparcin was licensed in Europe in 1975 and subse-
quently banned throughout the European Union in 1997 (6).
In Australia, the per capita consumption of avoparcin by
Australian agriculture is one of the highest in the world (5),
while in the United States avoparcin has never been licensed
for animal feed. The incidence of VRE infections in European
countries is relatively low compared with the high, increas-
ing rate in the United States, indicating that clinical use of
vancomycin may be the reason for differences observed
between the two populations.
The food chain has been proposed as a suspected source
for dissemination of VRE to the human population (6).
Should this be the case, one possible source is plants that
produce ready-to-eat foods. Enterococci can be found in the
environment of food-processing facilities, including those
producing ready-to-eat meat and poultry products, but the
incidence of vancomycin resistance among enterococci from
these facilities is not known. We investigated the presence of
VRE in 12 meat-processing plants in 8 U.S. states. 
The Study
A total of 446 swabs of floors and surfaces (in areas with
and without food contact) were obtained from 12 meat-pro-
cessing plants in 8 U.S. states during 1999. All processing
facilities produced ready-to-eat meat products. The number
of swabs collected at each plant ranged from 8 to 73. Swabs
were taken by using either a sterile gauze pad or a sterile
sponge moistened with Butterfield’s phosphate diluent. The
area covered by the swab depended on the sampling site. For
sampling floors, an area of approximately 1 square meter
was covered. All swabs were sent to the testing laboratory
within 24 hours of collection. Swab samples were enriched in
University of Vermont medium (UVM) and incubated at
30°C for 24 hours. Following enrichment, 0.1 mL of UVM
culture was transferred to Fraser broth for selective enrich-
ment and incubated at 35°C for 24 hours. All tubes that had
visible growth or a darkened appearance due to esculin
hydrolysis were streaked onto Bile Esculin Azide agar
(BEAA) and incubated at 35°C for 48 hours. A single typical
colony was selected from each sample and identified to genus
level on the basis of esculin hydrolysis, bile tolerance, and
colony morphology on BEAA. Enterococci were screened for
vancomycin resistance by the method of Klein et al. (3) with
some modifications. Enterococci isolates were subcultured
onto Mueller-Hinton agar supplemented with 32 µg/mL van-
comycin (MHV) to screen for high-level vancomycin resis-
tance. Sensitivity of the isolate was determined by the
confluence of bacterial growth on MHV plates after 48 hours
of incubation at 35° C. No growth indicated sensitivity to
vancomycin.
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Conclusions
The increasing prevalence of VRE in the United States
is generally attributed to the hospital use of antibiotics
(2,11). The meat-processing facilities examined in this study
all produce ready-to-eat products made from beef, pork, or
poultry. A total of 406 enterococci isolates from the plants’
packaging areas were examined for high-level vancomycin
resistance: 202 were isolated from food-contact areas and
134 from other areas and floors. No high-level vancomycin
resistance was demonstrated in any enterococci isolated
from the 12 meat-processing plant environments. These data
suggest that enterococci with VanA resistance phenotype are
uncommon in U.S. meat-processing facilities producing
ready-to-eat meat products.
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